The purpose of the new Center is to increase the scholarly education and training of physicians in addiction medicine, with a special emphasis on prevention and screening, brief intervention and referral to treatment , particularly for adolescents and adults. The Center will be directed by Richard Blondell, MD, Professor of Family Medicine at the University in Buffalo School of Biomedical and Medication Sciences. ‘Our objective can be to create systemic switch in medical education, medical practice and health care, to be able to provide evidence-based addiction prevention and treatment to adolescents and others who need it,’ said Dr. Blondell. ‘We are grateful to the Conrad N. Hilton Base for helping us establish this Middle to be able to better work toward this objective.’ ‘We're pleased to partner with The ABAM Base to create the National Middle for Physician Trained in Addiction Medication,’ said Steven M.Macro, M. Pfreundschuh, V. Di Raimondo, V. Ribrag, M. Uppenkamp, M. Klapper, W. Hiddemann, M. Unterhalt, and M.H. Dreyling: Treatment of Old Patients with Mantle-Cell Lymphoma Patients with mantle-cell lymphoma typically present with extensive disease and involvement of multiple lymph nodes as well as the spleen, bone marrow, bloodstream, and gastrointestinal tract. The median age group at diagnosis is about 65 years.1,2 Regular therapy for these individuals includes chemotherapy combined with anti-CD20 monoclonal antibody rituximab .2-4 Only a minority of patients have a complete remission, and relapse or progression usually occurs within 2 to 3 3 years, resulting in a standard survival of less than 5 years.